Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
PLoS One ; 12(5): e0177441, 2017.
Article in English | MEDLINE | ID: mdl-28493936

ABSTRACT

BACKGROUND: Lung cancer is a leading cause of cancer-related mortality globally. Folate helps to maintain DNA integrity and to regulate gene expression. Serum folate levels may affect the risk of several cancers, including lung cancer. In this study we evaluated the association between serum folate concentration and variations in genes involved in folate metabolism with lung cancer incidence in Poland. METHODS: The study included 366 lung cancer patients and 366 control subjects. We measured serum folate concentration and genotyped six variants in MTHFR, MTR and MTRR genes. The odds ratios of being diagnosed with lung cancer were calculated using conditional univariable and multivariable logistic regression with respect to folate level and genotypes. RESULTS: The mean serum folate level was lower in lung cancer cases than in control group (20.07 nmol/l vs. 22.52 nmol/l, p = 0.002). The odds ratio for lung cancer declined with increasing serum content of the folate. The folate concentration of >25.71 nmol/l (IVth quartile) in comparison to <15.92 nmol/l (Ist quartile) was associated with an odds ratio of 0.61 (95%CI 0.40-0.95, p = 0.03). The analysis of variations in MTHFR, MTR and MTRR genes did not reveal any significant difference between lung cancer cases and controls in univariable and multivariable analyses. CONCLUSION: In this case-control study, lower serum folate concentrations were associated with a higher risk of lung cancer diagnosis. Although previous findings have been somewhat mixed, our results add to the evidence that circulating folate levels may be an indicator of lung cancer risk.


Subject(s)
Folic Acid/blood , Lung Neoplasms/blood , Lung Neoplasms/genetics , 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Ferredoxin-NADP Reductase/genetics , Genotype , Humans , Incidence , Logistic Models , Lung Neoplasms/epidemiology , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Middle Aged , Odds Ratio , Polymorphism, Single Nucleotide/genetics , Risk Factors
2.
Int J Cancer ; 141(2): 336-341, 2017 07 15.
Article in English | MEDLINE | ID: mdl-28411367

ABSTRACT

The first aim of our study was to examine the association between common variants in VDR [rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), rs731236 (TaqI) and rs11568820 (Cdx2)] and lung cancer risk in the Polish population. Genotyping and statistical analysis which included Chi-square test with Yates correction and haplotype frequency analysis were performed on a series of 840 consecutively collected lung cancer patients and 920 healthy controls. The second aim was to evaluate the link between serum 25(OH)D concentration and the number of lung cancers in a subgroup of 200 patients. A separate control group that consisted of 400 matched (by age, sex, smoking habits and the season of blood collection) healthy individuals was used to avoid posterior adjustment on the matched variables. Statistical analysis with the use of Chi-square test with Yates was performed. We found no statistically significant difference in the distribution of the allels of studied VDR variants among cases and controls. A statistically significant over-representation of VDR haplotypes: rs731236_A + rs1544410_T [odds ratio (OR) = 2.43, 95% confidence interval (CI) = 1.11-5.32, p < 0.001], rs731236_G + rs1544410_T (OR = 1.54, 95% CI = 1.31-1.81, p < 0.001) and rs731236_G + rs1544410_C (OR = 0.04, 95% CI = 0.03-0.07, p < 0.001) was detected. We found a tendency toward an increased number of lung cancers among individuals with low serum levels of 25(OH)D. To answer the question, whether VDR can be regarded as lung cancer susceptibility gene and low 25(OH)D serum levels is associated with lung cancer occurrences, additional, multicenter study needs to be performed.


Subject(s)
CDX2 Transcription Factor/genetics , Lung Neoplasms/genetics , Polymorphism, Single Nucleotide , Receptors, Calcitriol/genetics , Vitamin D/analogs & derivatives , White People/genetics , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Haplotypes , Humans , Lung Neoplasms/metabolism , Male , Middle Aged , Poland , Vitamin D/blood
3.
Cancer Causes Control ; 23(7): 1065-74, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22576580

ABSTRACT

PURPOSE: Few studies have evaluated the role of micronutrients or trace elements in breast cancer development among BRCA1 mutation carriers. To investigate a possible role of dietary and environmental exposures on cancer risk, we undertook an exploratory study, using a matched case-control design (n = 48 cases and 96 controls), to evaluate the relationships between plasma levels of 14 micronutrients and breast cancer risk among BRCA1 mutation carriers in Poland. METHODS: We estimated the univariate odds ratios (OR) and 95 % confidence intervals (CI) for breast cancer associated with plasma levels for each of 14 micronutrients. RESULTS: Of the 14 analytes quantified, significant differences between cases and controls were seen for two (iron and retinol; p = 0.009 and p = 0.03, respectively). Women in the highest tertile of plasma iron had a 57 % lower risk, compared with those in the lowest quartile (OR = 0.43; 95 % CI 0.18-1.04; p for trend = 0.06). Increasing antimony levels were associated with an increased risk of breast cancer (p for trend = 0.05). Women in the highest tertile had a 2.43-fold increase in breast cancer risk compared with women in the lowest tertile (OR = 2.43; 95 % CI 1.00-5.91). CONCLUSIONS: This study provides some preliminary evidence regarding a role of diet, specifically iron and antimony, in the etiology of BRCA1-associated breast cancer. Prospective studies are necessary to confirm these findings.


Subject(s)
BRCA1 Protein/genetics , Breast Neoplasms/blood , Breast Neoplasms/genetics , Micronutrients/blood , Mutation , Trace Elements/blood , Adult , Aged , Analysis of Variance , Antimony/blood , Case-Control Studies , Female , Heterozygote , Humans , Iron/blood , Logistic Models , Middle Aged , Odds Ratio , Prospective Studies , Risk Assessment , Risk Factors , Young Adult
4.
J Mol Diagn ; 12(1): 82-90, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20007843

ABSTRACT

Mutations of genes associated with the mismatch repair mechanism and mutations of the APC gene are the most frequent causes of hereditary colorectal cancer. An iPLEX test combined with TaqMan genotyping assays was therefore developed to identify common recurrent mutations of those genes in the Polish population. We analyzed 349 DNA samples from 95 positive controls previously identified by sequencing and 254 unexamined individuals. The iPLEX test included two plexes, which comprised seven mutations of the APC gene and 29 mutations of three of the mismatch repair genes. TaqMan assays were designed for nine mutations not covered by the iPLEX assays: one mutation in the APC gene and eight mutations in the mismatch repair genes. Results were then verified independently by sequencing. Our combination method allowed detection of all recurrent mutations occurring in group of patients, followed by full analysis by DNA sequencing. With the exception of one false positive in the iPLEX test in the positive control group that could be assigned to contamination from neighboring wells rather than a detection error, given sufficient DNA concentration and quality, the designed iPLEX/TaqMan test had an accuracy of 100% for the designed assays. These results suggest that the combined iPLEX/TaqMan test is an outstanding tool for identification of recurrent mutations among hereditary colorectal cancer patients.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/diagnosis , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , DNA Mutational Analysis/methods , DNA/analysis , Genes, APC , Mutation , DNA/genetics , DNA Mismatch Repair , Genetic Testing/methods , Genotype , Humans
5.
J Plant Physiol ; 165(10): 1011-22, 2008 Jul 07.
Article in English | MEDLINE | ID: mdl-18242772

ABSTRACT

The aim of this experiment, conducted under greenhouse conditions, was to assess the influence of various H(2)SeO(3) concentrations added to soil (0.05, 0.15, and 0.45mMkg(-1)) on selenium and adenosine triphosphate (ATP) content, and on the activity of the ascorbate-glutathione cycle enzymes in green parts of wheat and oilseed rape. Selenium uptake by the test plants was found to vary, with content increasing from one developmental stage to the next over four stages of the developmental cycle. At the lowest H(2)SeO(3) dose (0.05mMkg(-1)), the wheat plants took up much more selenium than did the oilseed rape plants, while the amount of selenium taken up at higher doses (0.15 and 0.45mMkg(-1)) was markedly higher in rape. The increasing Se content in the wheat to about 10mgkg(-1) (in the dark) and to about 16mgkg(-1) (in the light) was accompanied by a concurrent increase in the ATP content, which remained unchanged in the light-exposed plants, while clearly decreasing in those kept in the dark. On the other hand, the ATP content of the light-exposed oilseed rape was maintained at a stable level to about 10mg Sekg(-1), following which ATP content was observed to decrease. In contrast, the tendency for the ATP content to decrease appeared immediately in the dark. The increasing plant selenium concentration was accompanied by decreased APX activity in wheat, increased activity in oilseed rape, no major change in the dehydroascorbate reductase (DHAR) activity in oilseed rape and a slight increase in wheat to about 8mg Sekg(-1), followed by a reduction. The glutathione reductase (GR) activity in wheat differed from the activity of DHAR; an increase in the selenium content to about 8mgkg(-1) was accompanied by a distinct reduction, while a significant increase was observed at higher selenium contents; in oilseed rape, the activity was observed to increase slightly within a narrow range of selenium contents (up to 5mgkg(-1)), and to decrease thereafter.


Subject(s)
Adenosine Triphosphate/metabolism , Brassica rapa/enzymology , Selenium Compounds/metabolism , Triticum/enzymology , Ascorbate Peroxidases , Brassica rapa/growth & development , Brassica rapa/metabolism , Glutathione Reductase/metabolism , Oxidoreductases/metabolism , Peroxidases/metabolism , Triticum/growth & development , Triticum/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...